NCT06288867

Brief Summary

This study aims to address hip labral tears and compare between arthroscopic labral repair versus debridement.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Aug 2024

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 24, 2024

Completed
6 days until next milestone

First Posted

Study publicly available on registry

March 1, 2024

Completed
5 months until next milestone

Study Start

First participant enrolled

August 1, 2024

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2025

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2025

Completed
Last Updated

August 27, 2024

Status Verified

August 1, 2024

Enrollment Period

1.1 years

First QC Date

February 24, 2024

Last Update Submit

August 26, 2024

Conditions

Keywords

Hip ArthroscopyLabral RepairLabral DebridementAcetabular Labral Tear

Outcome Measures

Primary Outcomes (3)

  • Change from baseline in Hip Function, as measured by Hip Outcome Score (HOS)

    The HOS is a patient-completed measure that consists of an "Activities of Daily Living" subscale (17 scored items) and a "Sports" subscale (9 scored items) in which the response options are presented as 5-point Likert scales (Scores 0-4). Scores for each subscale range from 0% (least function) to 100% (most function).The highest potential score is 68, a higher score represents a higher level of physical function for both the ADL and sports subscales

    Baseline, 1 year

  • Change from baseline in Hip Function, as measured by Harris Hip Score (HHS)

    \<70 (poor result), 70-79 (fair result), 80-89 (good result) and \>90 (excellent result)

    Baseline, 1 year

  • Change from baseline in Pain, as measured by the Visual Analogue Scale (VAS)

    Scores are measured on a 100 mm VAS. The VAS ranges from 0 to 100 with 0 indicating no pain, and higher scores indicating greater pain

    Baseline, 1 year

Study Arms (2)

Labral Repair

ACTIVE COMPARATOR

Labral tears will be repaired with suture anchors.

Procedure: Arthroscopic Labral Repair

Labral Debridement

ACTIVE COMPARATOR

Labral Debridement will be done by electrocautery

Procedure: Arthroscopic Labral Debridement

Interventions

Patients with Hip Labral tears will be treated with labral repair

Labral Repair

Patients with Hip Labral tears will be treated with labral debridement

Labral Debridement

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Sex: both sexes.
  • Age: 18 years - 60 years.
  • Femoroacetabular impingement (FAI) including all types (cam, pincer, and combined).
  • Traumatic Labral tears

You may not qualify if:

  • Previous hip surgery.
  • Hip joint dysplasia, defined by both center edge (CE) angles \<25 degrees and Acetabular Index angle \>10 degrees.
  • Osteoarthritis grade \>2 according to Tönnis classification.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ain Shams University

Cairo, Egypt

RECRUITING

MeSH Terms

Conditions

Hip InjuriesFemoracetabular Impingement

Condition Hierarchy (Ancestors)

Wounds and InjuriesJoint DiseasesMusculoskeletal DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Karim A Salem, MD

    Ain Shams University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Karim A Salem, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

February 24, 2024

First Posted

March 1, 2024

Study Start

August 1, 2024

Primary Completion

September 1, 2025

Study Completion

December 1, 2025

Last Updated

August 27, 2024

Record last verified: 2024-08

Locations